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Department of EABSTRACTObjective: The purpose of this study was to evaluate changes in methodological quality and sample size in randomized
controlled trials (RCTs) of spinal manipulative therapy (SMT) for neck and low back pain over a specified period.
A secondary purpose was to make recommendations for improvement for future SMT trials based upon our findings.
Methods: Randomized controlled trials that examined the effect of SMT in adults with neck and/or low back pain
and reported at least 1 patient-reported outcome measure were included. Studies were identified from recent Cochrane
reviews of SMT, and an update of the literaturewas conducted (March 2013). Risk of biaswas assessed using the 12-item criteria
recommended by the Cochrane Back ReviewGroup. In addition, sample size was examined. The relationship between the
overall risk of bias and sample size over timewas evaluated using regression analyses, and RCTswere grouped into periods
(epochs) of approximately 5 years.
Results: In total, 105 RCTs were included, of which 41 (39%) were considered to have a low risk of bias. There is
significant improvement in the mean risk of bias over time (P b .05), which is the most profound for items related to
selection bias and, to a lesser extent, attrition and selective outcome reporting bias. Furthermore, although there is no
significant increase in sample size over time (overallP = .8), the proportion of studies that performed an a priori sample size
calculation is increasing statistically (odds ratio, 2.1; confidence interval, 1.5-3.0). Sensitivity analyses suggest no appreciable
difference between studies for neck or low back pain for risk of bias or sample size.
Conclusion: Methodological quality of RCTs of SMT for neck and low back pain is improving, whereas overall sample
size has shown only small and nonsignificant increases. There is an increasing trend among studies to conduct sample size
calculations, which relate to statistical power. Based upon these findings, 7 areas of improvement for future SMT
trials are suggested. (J Manipulative Physiol Ther 2014;37:523-541)
Key Indexing Terms: Manipulation; Spinal; Low Back Pain; Neck Pain; Methodology; Research; Sample Sizeeck and low back pain are common and disabling controlled trials (RCTs). These trials have been summarizedNdisorders in western society, which represent a greatfinancial burden.1,2 Therefore, adequate treatment
of neck and low back pain is important for patients, clinicians,
and health care policy makers. One widely used intervention
for neck and low back pain is spinal manipulative therapy
(SMT), which has been examined in numerous randomizedarcher, Department of Health Sciences, VU
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Vpidemiology and Biostatistics, EMGO-Institute,in recent systematic reviews,3-7 which have formed the basis
for recommendations in clinical guidelines.8-10
Recommendations on SMT vary across countries.
In Canada, France, the United States, New Zealand, and
Norway, SMT is considered a useful treatment, whereas
guidelines in other countries recommend it as an optionalhttp://dx.doi.org/10.1016/j.jmpt.2014.07.007
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such as Spain, recommend against its use.11 The reasons
for the various recommendations remain speculative but
are probably based upon the lack of convincing evidence and
the different weights allocated to other aspects of health care
such as adverse events, costs, availability, and preferences of
patients and care providers.
Differences in interpretation and uncertainty regarding
the effect of a particular intervention are influenced by the
methodological shortcomings and quality of reporting. In
short, RCTs, which lack methodological rigor, can
introduce biased results.12,13 Various international efforts
have been initiated as early as the mid 1990s to improve the
quality of reporting of RCTs, resulting in the CONsolidated
Standards Of Reporting Trials (CONSORT) statement.14
More recently, an extension of this statement was
published, which takes into consideration specific issues
when assessing RCTs of nonpharmacological interventions,
such as difficulties with blinding, the complexity of the
intervention, and potential influence of the care providers'
expertise.15 Furthermore, international efforts have been
initiated to evaluate the risk of bias of RCTs, which has
resulted in criteria lists as well as their operational
definitions. A good example is the Cochrane Collaboration,
which published a tool for risk of bias assessment,16 which
has been modified for neck and low back pain.17 Despite
these efforts, a recent study, which evaluated the method-
ological quality of conservative interventions for low back
pain, failed to detect a clear improvement in quality over
time.18 A more recent effort, which evaluated the quality of
pharmacological and nonpharmacological treatments for
chronic low back pain, also failed to detect a clear
improvement over time.19 An earlier study examined 61
trials of SMT for low back pain but not neck pain.20
Including additional studies and studies of the neck would
provide more statistical power to detect trends over time
and would allow us to determine if there were essential
differences in quality and size of studies for the neck and
low back.
Therefore, the purpose of this updated analysis is
to evaluate the methodological quality in RCTs of SMT
for neck and low back pain and to determine whether the
risks of bias and sample size of these trials are improving
over time. This study identifies areas for improvement and
makes recommendations for future trials.METHODS
Data Source
Randomized controlled trials included in this analysis
were identified from the existing Cochrane reviews of SMT
for neck and low back pain.5-7 An update of the searches
was conducted by one of the authors (RvE) in PubMed in
March 2013 (Appendix A). These results were supplementedby a search of the references, other existing systematic reviews,
and contact with content experts.
Two authors (SMR and RvE) screened the titles and
abstracts of all recently identified studies, and all publica-
tions thought to fulfill the inclusion criteria were evaluated.
Studies published in Chinese for which there was no direct
translation available were excluded, and we accepted only
full articles. The following studies were included: RCTs
that evaluated the effect of SMT on adults (≥18 years of
age) with either neck or low back pain and evaluated at least
1 patient-reported outcome measure (eg, pain, functional
status, recovery). Studies were included only if it was
possible to distil the effect of SMT as compared with other
types of treatments, such as sham SMT, ineffective and
other effective therapies or when added to an existing
therapy, and not for example when SMT was compared to
different dosages, as in dose-response investigations. In
addition, studies were included regardless of the duration of
pain, whereas studies that evaluated subjects with sciatica
only were excluded.
Intervention. Spinal manipulative therapy was defined as
any “hands on” therapy directed at the spine and includes both
high-velocity, low-amplitude spinal manipulation as well as
any mobilization technique of the spine. Studies, which
evaluated SMT as part of a multimodal treatment approach
and, therefore, difficult to evaluate the effect of SMT, were
excluded. Studies were also excluded if the association with
neck or low back pain was unclear (eg, coccydynia).Data ExtractionRisk of Bias. Data extraction and assessment of risk of bias
were evaluated using the 12-item criteria list recommended by
the Cochrane Back Review Group (Table 1 and operationa-
lization of these items are to be found in Appendix B).17 These
criteria help to evaluate the major areas that threaten internal
validity including selection bias (items 1, 2, and 9),
performance bias (items 3, 4, 10, and 11), attrition bias
(items 6 and 7), detection bias (items 5 and 12), and selective
reporting bias (item 8). Each itemwas scored as “yes,” “no,” or
“unsure,” where “yes” indicate that the criterion has been met,
suggesting a low risk of bias. The total risk of bias score is the
total number of items rated as low risk of bias, and trials with a
low risk were defined as those fulfilling 6 or more of these
items.13 In addition to examining the overall risk of bias, we
also examined the individual criteria items.
Trials identified in the update were assessed by pairs
of reviewers independent of one another, and a third
reviewer was consulted if deemed necessary. To check for
consistency, RvE compared his analysis from studies for the
neck to the respective Cochrane review. For studies
identified in the update, the results from the risk of bias
assessment were sent to the corresponding authors with the
opportunity for them to provide additional input, which was
considered in our final assessment.
Table 1. The 12-Item Criteria List Used to Evaluate Risk of Bias
Risk of Bias Items Assessment
Randomization and allocation
1. Was the method of sequence
generation adequate?
Yes/No/Unsure
2. Was the treatment allocation concealed? Yes/No/Unsure
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Quality of Trials on Spinal ManipulationVolume 37, Number 8Sample Size. In addition to examining risk of bias, we also
examined sample size for the entire study as well as sample
size of the SMT and control groups, separately. Furthermore,
we examined whether an a priori sample size calculation had
been performed and whether this sample had been reached
within a margin of 10%.Blinding patient/provider/outcomes assessor
3. Was the patient blinded to the intervention? Yes/No/Unsure
4. Was the care provider blinded
to the intervention?
Yes/No/Unsure
5. Was the outcome assessor blinded
to the intervention?
Yes/No/Unsure
Reporting of the data
6. Was the drop-out rate described
and acceptable?
Yes/No/Unsure
7. Were all randomized participants analyzed
in the group to which they were allocated?
Yes/No/Unsure
Selective reporting
8. Are reports of the study free of suggestion
of selective outcome reporting?
Yes/No/Unsure
Other potential sources of bias
9. Were the groups similar at baseline regarding
the most important prognostic indicators?
Yes/No/Unsure
10. Were co-interventions avoided or similar? Yes/No/Unsure
11. Was the compliance acceptable in all groups? Yes/No/Unsure
12. Was the timing of the outcome assessment
similar in all groups?
Yes/No/Unsure
Reprinted with permission from Furlan AD et al. 2009 updated method
guidelines for systematic reviews in the Cochrane Back Review Group
Spine 2009;34:1929-1941.Data Analysis
Relevant descriptive trial characteristics, including the
year of publication and sample size for both SMT and
control group(s) as well as all data relating to risk of bias,
were extracted. Data, which are skewed, such as sample
size, were expressed as median and interquartile ranges
(IQR), whereas all other data are presented as a mean and SD.
For the sample size calculations, data from multiple control
groups were treated as discrete entities, meaning each control
group was treated as a separate unit of measure.
To examine changes in sample size and risk of bias over
time, RCTs were grouped into epochs of approximately 5
years. However, for the first epoch, a larger period was used
(ie, 15 years) because there were too few studies. The dates
used for the individual studies correspond to the year of
publication. In the case of multiple publications, the most
important publicationwas used,whichwas left to the discretion
of the research team.
Regression Analyses. Linear regression analysis was con-
ducted to test trends in time for the overall risk of bias.
The total score for risk of bias was used as the dependent
variable. The epochs were analyzed as a categorical variable
using the first epoch as reference category. P b .05 was
considered statistically significant. No other covariates were
entered into the analyses. Log transformations were used
when data were skewed. To determine whether there are
changes in the individual risk of bias items over time, graphs
were generated and visual inspected. However, we did
not formally test this because of possible “data dredging” and
the chance of a false-positive finding but felt instead that
interpretation of the figures gave a better reflection of the
results. We also conducted linear regression analyses for
sample size. For these analyses, we used the natural logarithm
of the sample size as the outcome variable. We first explored
whether the relation with time (epochs) was linear, but this
was not the case. Next, we added a quadratic term for epoch,
but this did not significantly improve themodel; therefore, the
final model includes time (epoch) as a categorical variable.
Finally, to examine the relation between time and sample size
calculations, we conducted a logistic regression analysis with
epochs treated as a continuous variable.
The analyses presented here are based upon the pooled
RCTs for neck and low back pain. Sensitivity analyses were
conducted for neck and low back pain separately. All analyses
were conducted in SPSS version 20 (IBM Corp., Armonk,
NY). All graphs were generated by SigmaPlot version 11
(Systat Software Inc., San Jose, CA)..RESULTS
Included and Excluded Studies
In total, 105 studies were included, which examined
15,539 subjects. In total, 68 studies were included for low
back pain,21-81 including an additional 5 studies identified
in the update82-86 and 2 studies, which were previously
excluded.87,88 In total, 37 studies were included for neck
pain,89-110 including an additional 15 studies identified in
the update111-125 (Fig 1).
In total, 25 trials examined the effects of SMT for
acute22,24,28,29,31,32,35,39,42-44,47,48,53,57,63,65,68,71,73,83,87,88,102,116;
8 trials, for subacute50,51,89,96,107,114,120,122; and 43
trials, for chronic neck and/or low back pain,26,27,30,34,36-38,
40,41,45,49,52,55,56,59-64,66,72,75-77,79,82,84-86,90,95,98,
99,103,106,110,111,113,117-119,123 as well as 17 studies, which
examined subjects with an unspecified duration
of pain23,54,70,80,81,93,97,100,101,104,108,109,112,115,121,124,125 in
addition to 13 trials in which it was unclear. 21,25,
33,46,58,67,69,74,78,91,92,94,105 Four studies included subjects
with both neck and low back pain.55,60,71,72
Studies were excluded for the following reasons: studies
that examined the effects of SMT as part of a multimodal
intervention,126-140 the effects of SMT were researched on
sciatica exclusively,141-146 quasirandomized studies,147-151
studies that did not examine treatment effect,152 -154
studies with no patient-reported outcome measure,155-167
Fig 1. Detailed flowchart illustrating the trial search and selection of studies. RCT, randomized controlled trial; SMT, spina
manipulative therapy.
ig 2. Number of RCTs that have examined the effects of spinal manipulative therapy for neck and low back pain, presented in the used
me epochs of approximately 5 years.Note: The epochs refer to the year of publication and the years of the first and last epoch have been
odified due to the size of the epochs.
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ti
mand 2 studies that examined shoulder pain exclusively
and cervicogenic headache exclusively.168,169 Five studies
included in the Cochrane review on neck pain were excluded
for the following reasons: study purpose other than
effect,170,171 study already identified in the Cochrane review
for low back pain,60 no patient-reported outcome measure,172
and an article in Chinese with no translation available.173TRENDS OVER TIME
Total Number of Studies
The number of published studies appears to increase
steadily over time (Fig 2). A cursory examination of registered
trials in ClinicalTrials.gov and the International Clinical TrialslRegistry Platform search portal suggests that numerous trials
for neck and low back pain are currently being conducted and
have yet to be published.Risk of Bias
In total, 41 RCTs (39%) met the criteria for a low risk of
bias (Table 2), of which 35 trials were published since 1999.
The overall mean (SD) risk of bias score was low (4.6 [2.2])
with the score increasing steadily over time (Table 3). Results
of the linear regression analysis suggest that the mean risk of
bias increases significantly for each epoch from 1990 when
comparedwith the first epoch (1970-1984). However, only in
the last period (2010+) did more than half the studies have a
low risk of bias, namely, 68%.
Table 2. Risk of Bias Assessment for Studies on Spinal Manipulative Therapy for Neck and Low Back Pain
Risk of Bias Item
Author, Year 1 2 3 4 5 6 7 8 9 10 11 12 Total RoB
Andersson, 1999 + + − − − + − ? + − − + High risk
Bergquist-Ullman, 1977 + ? − − − − − ? ? ? − + High risk
Beyerman, 2006 ? ? − − − ? ? ? ? ? ? ? High risk
Bitterli, 1977 − ? − − − − − ? − − ? − High risk
Brennan, 2006 + + − − − − − ? ? ? + + High risk
Bronfort, 1989 ? ? − − − + − − − ? ? + High risk
Bronfort, 1996 + + − − − − + − + + + + Low risk
Bronfort, 2011 + + − − − + + + + ? ? + Low risk
Bronfort, 2012 + + − − − + + + + + + + Low risk
Cassidy, 1992 ? ? ? − − + + − ? + + + High risk
Cecchi, 2010 + + − − − + + ? + ? + + Low risk
Cherkin, 1998 + + − − − + + ? + − ? + Low risk
Childs, 2004 + + − − − − + ? + ? − + High risk
Chown, 2008 + ? − − − − ? − + ? − + High risk
Cleland, 2005 + + ? − − + + + + + + + Low risk
Cleland, 2009 + ? − − − + + + + ? ? + Low risk
Cleland, 2010 + + − − − + + ? + ? ? + Low risk
Coppieters, 2003 + + − − − + − − + − + + Low risk
Cramer, 1993 ? ? − − − + + ? ? ? ? + High risk
David, 1998 + ? − − − + − ? − + − + High risk
Doran, 1975 ? ? − − − − − ? ? − − + High risk
Dunning, 2012 + + − − − + + + + + + + Low risk
Egwu, 2008 − ? − − − + − ? − + + − High risk
Escortell-Mayor, 2011 + + − − − + + ? + ? ? + Low risk
Evans, 1978 ? ? − − − + ? − + + ? + High risk
Evans, 2012 + + − − − + + + + ? + + Low risk
Farrell, 1982 ? ? − − − + ? ? + ? ? + High risk
Fernandez-de-las-Penas, 2004 + ? ? − − + + ? ? − + + High risk
Ferreira, 2007 + + − − − + + + + ? + + Low risk
Gemmell, 1995 + ? − − − + + ? ? + + + Low risk
Ghroubi, 2007 + ? ? − ? + ? − + ? + + High risk
Gibson, 1985 ? ? ? − ? + ? − − ? + + High risk
Giles, 1999 + ? − − − − − ? − ? + + High risk
Glover, 1974 + ? − − − ? ? − ? ? ? + High risk
Goldby, 2006 + ? − − − + − − + ? − + High risk
Gonzalez-Iglesias, 2009 + + ? − ? + + ? + ? ? + Low risk
Gudavalli, 2006 + + − − − − − − + ? ? + High risk
Hadler, 1987 ? ? − − − + − ? − ? ? + High risk
Hallegraeff, 2009 + + − − − + + ? − ? + + Low risk
Hancock, 2007 + + − − − + + + + + + + Low risk
Hemmila, 2002 + + − − − + ? − + − + + Low risk
De Hertogh, 2009 + ? − − − − + + + ? − + High risk
Herzog, 1991 ? ? − − − ? − ? ? ? ? + High risk
Hoehler, 1981 ? ? ? − ? − ? ? − ? ? − High risk
Hoiriis, 2004 + ? − − − − + ? ? ? ? + High risk
Hondras, 2009 + + − − − − + + + ? − + Low risk
Howe, 1983 + ? − − − + ? ? − − + ? High risk
Hsieh, 2002 + ? − − − + + ? + + − + Low risk
Hurley, 2004 + + − − − − + ? + ? + + Low risk
Hurwitz, 2002 + + − − − + + + + − − + Low risk
Hurwitz, 2002a + ? − − − + + + + + ? + Low risk
Juni, 2009 + + − − − + + + ? + + + Low risk
Kamali, 2012 ? ? − − − + + ? − + + + High risk
Kanlayanaphotporn, 2009 + + ? − − + + ? + + + + Low risk
Kanlayanaphotporn, 2009a + + ? − − + + ? − + + + Low risk
Kinalski, 1989 ? ? − − − ? ? ? ? ? ? ? High risk
Koes, 1992 + + − − − + + − + − ? + Low risk
Krauss, 2008 ? − − − − + + ? − − + + High risk
Lau, 2011 + + − − − + + ? + ? + + Low risk
Leaver, 2010 + + − − − + + + + − + + Low risk
(continued on next page
527Rubinstein et alJournal of Manipulative and Physiological Therapeutics
Quality of Trials on Spinal ManipulationVolume 37, Number 8)
Table 2. (continued)
Risk of Bias Item
Author, Year 1 2 3 4 5 6 7 8 9 10 11 12 Total RoB
Licciardone, 2003 + ? ? − ? − ? − + + ? + High risk
MacDonald, 1990 ? ? − − − + − ? + ? + + High risk
Martinez-Segura, 2006 + ? ? − + + − − + ? + + Low risk
Martinez-Segura, 2012 + + − − + + − − + + + + Low risk
Meade, 1990 ? ? − − − − − ? + ? − + High risk
Mohseni-Bandpei, 2006 ? ? − − − − ? − + ? ? + High risk
Muller, 2005 + ? − − − − − − + ? − + High risk
Murphy, 2010 ? ? − − − − − ? + ? ? + High risk
Nilsson, 1997 ? ? ? − ? + + ? + − + + High risk
Paatelma, 2008 + ? − − − − + − + ? ? + High risk
Parkin-Smith, 1998 ? − − − − ? ? + + − ? + High risk
Petersen, 2011 + + − − − − + + + ? ? + Low risk
Pool, 2010 + + − − − + + + + ? ? + Low risk
Pope, 1994 ? ? − − − + ? − + ? + + High risk
Postacchini, 1988 ? ? − − − + − ? ? − ? + High risk
Puentedura, 2011 + + − − − − + ? − ? ? + High risk
Rasmussen, 1979 ? ? − − − + − ? ? ? ? + High risk
Rasmussen, 2008 ? ? − − − − + − + ? + + High risk
Rasmussen-Barr, 2003 + ? − − − − ? ? + ? ? + High risk
Rupert, 1985 ? ? ? − ? ? ? − + ? ? ? High risk
Saavedra-Hernandez, 2012 + + − − − + − ? + ? ? + High risk
Saayman, 2011 + + − − − + + ? + ? ? + Low risk
Sanders, 1990 + ? − − − + + ? + + + + Low risk
Savolainen, 2004 ? − − − − − − ? − − − + High risk
van Schalkwyk, 2000 − ? − − − + + + ? ? ? + High risk
Seferlis, 1998 ? ? − − − − + ? ? ? ? + High risk
Senna, 2011 + ? ? − ? − − ? + ? ? + High risk
Shearar, 2005 + ? − − − + − ? + + ? + High risk
Sims-Williams, 1978 ? ? ? − ? + ? ? − ? ? + High risk
Sims-Williams, 1979 ? ? ? − ? + ? ? ? ? ? + High risk
Skargren, 1997 ? ? − − − − − ? + − ? + High risk
Skillgate, 2007 + + − − − + + + + ? ? + Low risk
Sloop, 1982 + ? + − + − ? − ? − ? + High risk
Sutlive, 2009 + + − − − + + ? + + + + Low risk
Triano, 1995 + + ? − ? − − ? ? + + + High risk
UK BEAM, 2004 + + − − − − + + + ? ? + Low risk
Vismara, 2012 + + − − − + − ? ? + + + Low risk
Waagen, 1986 ? ? + − + − ? − + ? ? + High risk
Walker, 2008 + + − − − + + ? − ? + + Low risk
Wilkey, 2008 + + − − − + ? ? + ? − + High risk
Wood, 2001 − ? − − − + + ? + + ? + High risk
Wreje, 1992 ? ? ? − ? + − ? − ? + + High risk
Yurkiw, 1996 + ? ? − − + + ? − + + + Low risk
Zaproudina, 2009 + + − − − + − + + ? ? − High risk
Zylbergold, 1981 ? ? − − − ? ? ? ? ? ? ? High risk
ROB, risk of bias. “+” means fulfilled, “−” means not fulfilled, and “?” means insufficient information to evaluate the criterion.
Item 1: sequence generation; Item 2: treatment allocation; Item 3: patient blinded; Item 4: care provider blinded; Item 5: outcomes assessor blinded; Item 6
drop-out rate described; Item 7: intention-to-treat; Item 8: selective outcome reporting; Item 9: similar baseline characteristics; Item 10: use of co
interventions; Item 11: compliance with the intervention; and, Item 12: similar timing of the outcomes.
Note: For a full description of the items, see Appendix B. Operationalization of the risk of bias criteria.
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Figure 3. Items that evaluate selection bias demonstrate
a positive trend (Fig 3a), whereas other items such as
selective outcome reporting and intention to treat also
demonstrate trends toward improvement, but not as
pronounced. Items such as reporting of cointerventions,
compliance, or incomplete outcome data demonstrate
varying change with time, whereas the item related to:
-timing of follow-up measurements remains high throughout
all epochs. Despite improvements in many of these items,
performance bias and selective reporting bias remain
problematic (Fig 3b and e). Variation might be due to the
few number of studies in some epochs.Risk of Bias: Unclear Items. Trends over time for studies scoring
items as “unclear” are depicted in Figure 4. Inmore than half of
all studies, 3 items (ie, treatment allocation, selective reporting,






Sample Size—SMT Group Sample Size—All Control Groups Total Sample Size Risk of Bias
Median (IQR) Median (IQR) Median (IQR) Mean (SD) Low Risk of Bias (%)
1970-1984 13 21 (11-53) 25 (13-74) 52 (38-95) 2.2 (1.1) 0
1985-1989 7 34 (11-68) 42 (26-74) 109 (29-145) 2.0 (1.3) 0
1990-1994 9 51 (17-69) 29 (19-48) 95 (37-210) 3.9 (1.9) ⁎ 22
1995-1999 12 44 (20-88) 43 (19-71) 126 (36-202) 4.5 (1.7) ⁎ 33
2000-2004 15 60 (29-171) 48 (22-123) 131 (47-240) 4.9 (1.8) ⁎ 47
2005-2009 30 37 (29-64) 43 (30-64) 101 (60-236) 5.3 (2.1) ⁎ 47
2010 + 19 47 (20-83) 70 (33-90) 107 (60-210) 6.3 (1.9) ⁎ 68
Total 105 43 (23-74) 44 (23-72) 95 (47-199) 4.6 (2.2) 39
IQR, interquartile range; RCT, randomized controlled trial, SMT, spinal manipulative therapy.
Note: The values for risk of bias represent the number of items that were fulfilled out of the maximum of 12.
⁎ Pb .05 when compared to the first epoch.
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appears to be a trend toward better reporting over time, which
is most pronounced for items related to selection bias.Sample Size
Sample size ranged from 1489 to 1334,75 and the median
(IQR) sample size for all RCTs is 95 (47-199) (Table 3).
Although the sample size appears to increase over time, this
is not statistically significant (overall P = .79). There appear
no important differences in sample size between the control
or SMT group.Sample Size Calculation. More than one-third of the studies
(n = 37) conducted an a priori sample size calculation for 1
or more of the (primary) outcomes.24-31,36,41,43,44,49,51,
53,55,56,58,72,73,75,84,86,102,103,111-115,117,119-124 In addition, 7
studies presented a sample size calculation, but it was unclear
which outcome this was based upon.23,40,59,69,77,118,125 Of
these 44 studies, most recruited sufficient subjects with the
exception of a few studies (taking into account a 10% margin
difference between those powered to be recruited and those
actually recruited).25,30,40,119,125 Six studies performed
post hoc sample size calculations to address the possibility
of a type II error.87,89-91,99,138
The percentage of trials for which an a priori sample size
was calculated increased from 0% in studies before 1985 to
63% in studies after 2009. For studies that conducted an a
priori sample size calculation and recruited sufficient subjects
(within the aforementioned margin of error), the total median
sample size was 136 (IQR, 83-249), whereas the total median
sample size for the remaining studies was 71 (IQR, 36-132).
The results of the logistic regression analysis for the relation
between sample size calculation and epoch resulted in an
odds ratio (OR) of 2.1 (confidence interval, 1.5-3.0), meaning
the odds of an a priori sample size calculation increasedwith a
factor 2.1 between subsequent time epochs.Sensitivity Analyses
We examined the trends over time separately for neck
and low back trials for both risk of bias and sample sizeand compared these results to the pooled analyses.
These results were similar to those of the main pooled analyses
(data not shown); however, it is important to note that these
results were not formally tested because of the reduced power.
In addition,we conducted a stratified analysis to determine
whether those studies that conducted an a priori sample size
calculation were methodologically better than those that did
not. In short, we found that the mean (SD) risk of bias (RoB)
was 5.7 (2.1) for the former group and 3.8 (2.0) for the latter
group indicating that performing a sample size calculation
might be a good indicator of a better quality study. However,
this was a post hoc analysis and, therefore, should be
considered hypothesis generating. Future analyses with
primarily new studies would be necessary to confirm
this finding.DISCUSSION
Our analysis of trials of SMT for neck and low back pain
provides insight into developments in methodological and
reporting quality over the past 40 years. The results suggest
that the methodological quality of studies is improving.
This is important when analyzing the quality of trials and,
therefore, interpreting the potential effect. To some extent,
it is remarkable that despite international initiatives, such as
the CONSORT statement,14 only marginal gains have been
made. However, this must be considered in light of the
therapy being evaluated. For example, for therapies such as
SMT, it is difficult if not impossible to prevent bias
associated with blinding (ie, it is not possible to “blind” the
care provider). Furthermore, given that the primary
outcomes are self-report measures, trials are “doubly
punished” when the patient is not blinded because the
patient becomes also, by de facto, the outcome assessor.
Nevertheless, performance bias is but one construct of
methodological quality, and studies that do not “blind” their
patients or practitioners may still be considered to have a
low risk of bias even if other constructs are not entirely
conducted well. Regardless which criteria are scored
Fig 3. Proportion of RCTs on spinal manipulative therapy for neck and low back pain, which fulfilled each of the risk of bias criteria
(and thus have a low risk of bias), divided into the following: selection bias (a), performance bias (b), attrition bias(c), detection bias
(d), and selective reporting bias (e). RCT, randomized controlled trial.
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Fig 4. ProportionofRCTsonspinalmanipulative therapy forneckand lowbackpainwhereeachriskofbiascriterionwas ratedunclear,divided into the
following: selection bias (a), performance bias (b), attrition bias (c), detection bias (d), and selective reporting bias (e). RCT, randomized controlled trial
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criteria are considered to have a low risk of bias. Therein
also belies a problem because it assumes that all criteriaweigh
equally, and one could argue that randomization, for
example, specifically treatment allocation, is perhaps the
most important feature of trials.12 Although this is likely to be
disease specific, this represents an area for future analysis.
In comparison with other studies that have examined
trends in methodological quality over time, previous analyses
have demonstrated slight overall improvement, which was
restricted to a few specific methodological aspects.18,19
However, those analyses were based upon a rather wide array
of conservative interventions, including pharmacological
studies, whereas other analyses restricted to physical therapy
interventions have demonstrated clear improvement in
methodological quality of RCTs over time.174
Although our analysis demonstrates that sample size
seems to increase with time, especially between the first and
latter epochs, differences were not statistically significant.
In contrast, we were able to detect a linear trend in the odds
of an a priori sample size calculation over time, suggesting
that trials are increasingly sufficiently powered to be able to
detect statistically clinically important differences between
SMT and the control group(s). This might represent a point
of discrepancy. Interestingly, we observed that trials that
performed an a priori sample size calculation had
considerably larger median sample sizes than those trials
that did not. This means that the discrepancy might be less
pronounced than our statistical tests indicate. Regardless, the
fact that a priori sample sizes are increasingly being
performed is good news and suggests that the chance of a
type II statistical error is becoming increasingly less. One
potential explanation for this observation might be related to
the inclusion of pilot studies in our analysis. Approximately
one-tenth of the studies (n = 9) included in this analysis are
self-confessed pilot studies.79,82,89-91,94,101,123,175 These the-
oretically precede larger trials and are conducted to determine
the feasibility of a study but are not designed to evaluate
treatment effect. As best aswe can ascertain, only one of these
pilot studies175 went on to conduct a full-scale larger trial,
suggesting that the original objective of the other 8 studies
might have been to examine treatment effect and not
feasibility but failed in their attempt to recruit sufficient
subjects and subsequently were later labeled a “pilot study”
by the authors. However, this remains speculation.
It is important to consider the pitfalls of sample size
calculations. First, there is no consensus what constitutes a
clinically important difference on the primary outcome
measure. Second, there is a range of plausible values for the
variance, and it is widely accepted to choose a power (1 − β)
between 80% and 90%. Differences in values for these input
parameters can profoundly influence the outcome of the
sample size calculations. This means that, in practice,
researchers might be influenced to choose input values,
which are based upon what is feasible in practice rather thanwhat the expected effect might be. This might provide an
explanation for the observation that although the proportion
of studies that performed sample size calculations steadily
increases over time, the actual sample size seems to reach a
ceiling between the period 1995 and 2000. Based upon this
and to improve transparency, we suggest that trial authors
better motivate the reasons for making decisions surrounding
these calculations.
The findings of this study are important for several reasons.
First, studies with a high risk of bias influence our
interpretation of the results and our confidence in the estimate
of the treatment effect, which is typically overestimated by
these types of studies. By identifying the individual method-
ological criteria where conduct of the study or reporting is still
lacking, we can improve quality of these studies in the future.
Second, studies with insufficient sample size run a greater risk
of a type II error and, therefore, lack the statistical power to
refute the null hypothesis. Although this problem can, in
principle, be circumvented in meta-analyses (as long as the
studies are of sufficient homogeneity in terms of study
population, intervention, comparison therapy, outcome mea-
sure, and time of measurement to warrant pooling), clinicians
and policymakers are likely tomisinterpret these small studies,
viewing them as “proof” that the intervention is ineffective and,
thus, potentially incorrectly base their care on these findings or
result in continued delivery of an ineffective (and potentially
harmful) therapy. Third, although sample size calculations are
designed to ensure researchers recruit sufficient subjects to
demonstrate a statistically significant difference between the
intervention and comparison therapy, input values are likely to
be influenced by feasibility rather than expected treatment
effect. Therefore, the recruitment of subjects according to these
calculations is not necessarily a guarantee that the statistical
power in studies is sufficient. Finally, if the rigor of designing,
conducting, and reporting on trials of SMT does not improve,
future studies are not likely to add anything new to our current
knowledge. In addition, the number of new trials is increasing
rapidly meaning that we run the risk of investing a lot of effort
and money with no little return of the investment.RECOMMENDATIONS
In light of these findings, we offer tangible suggestions
for improvement for future trialists, which can be divided
into reporting and study design.
Recommendation 1: Researchers developing and reporting
trials. Although the methodological
quality of trials is clearly improving,
it is essential that trialists design studies
to meet the requirements of CON-
SORT. All authors who are conducting
RCTs should be familiar with
these standards, and their manuscripts
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Recommendation 2: Researchers registering trials. Trialists
must register their protocol, which
serves 2 functions: (1) it gives an
indication of possible publication bias
and (2) it allows the reader to determine
if there is possible selective reporting
bias. Although this has been required
since July 2005, most trials evaluated
here and published in the last 5 years
still did not report this. Furthermore,
trialists need to include information
regarding the potential use of coin-
terventions during the follow-up peri-
od. Surprisingly, this is not included in
the CONSORT statement.
Recommendation 3: CONSORT and trial registration report-
ing by journals. Journals publishing
RCTsof SMTneed to adoptCONSORT
recommendations and need to be famil-
iar with these standards. Editors should
request that authors provide information
in their manuscripts to demonstrate that
clinical trials have been registered.
Recommendation 4: SMT descriptions. Specific information
regarding the use of SMT in the trial is
often lacking. It would be helpful for
clinicians and other readers if details of
the therapy are better described, specif-
ically, frequency, dosage, and timing of
the therapy prescribed and delivered
rather than report simply the average
number of treatments given. The next
step is to establish recommendations for
reporting of trials of SMT, which could
serve as a supplement to CONSORT.
Recommendation 5: Blinding. Blinding (or masking) of
subjects in trials of nonpharmacologi-
cal interventions remains a problem,
and SMT is certainly no exception. It is
questionable to what degree blinding
is relevant.Although adequate blinding
is absolutely necessary when compar-
ing an intervention to a sham treatment,
this is much less relevant for pragmatic
studies where experimental interven-
tions are typically compared with
standard therapies, such as “usual
care.” Alternatives might be to query
the beliefs of the patients, for example,
to measure treatment credibility, which
refers to how believable, convincing,
and logical the treatment seems.176
Treatment expectancy, which is anoth-er aspect of a patients' belief, refers to
the improvement the patient believes
will be achieved, and there is evidence
from cognitive behavioral therapy that
the latter is amuch stronger predictor of
outcome.177 Although these are clearly
different measures than blinding be-
cause blinding requires that competing
treatments be indistinguishable from
one another, future studies might
consider including these constructs.
Recommendation 6: Multicenter studies. There is evidence
that multicenter studies demonstrate
smaller effect sizes than single-center
studies.178 Although we cannot know
whether the effect sizes from multicen-
ter studies give a better reflection of the
“real” treatment effect, it might serve
science well if trialists used multicenter
methods for data collection. At the very
least, use of multiple locations might
increase the likelihood of recruiting
sufficient subjects.
Recommendation 7: Patient selection. Although execution
and proper reporting for RCTs of SMT
are essential, these alone are not likely to
lead to any new insights. It is essential
that we also focus our attention on other
areas, such as identification of sub-
groups likely to respond to care and
better patient selection (thus reducing
heterogeneity in the sample population).LIMITATIONS
The most important limitation to this study includes
insufficient studies per epoch, which made statistical analyses
difficult. In addition the inclusion of multiple review authors
who assessed the risk of bias might have introduced
differences in interpretation of the methodological quality
items. We tried to offset any differences by defining the
operationalization as concretely as possible. In addition, lack
of assessor blinding in studies with emphasis on self-reported
outcomes remains a problem when blinding is challenging.
Lastly, 1 criterion item deserves particular attention, selective
outcome reporting. This is a relatively new criterion that is
used to determine whether an outcome was measured, but not
reported. This is a particular problem for negative (or
undesirable) outcomes. The consequence is an intervention
might be interpreted to be more effective than it actually is. To
properly assess this item, it is necessary to compare an existing
protocol to the outcomes that were actually reported. For older
studies, this is particularly problematic because protocols have
only recently come to be published and, therefore, older
studies might be unjustly penalized. One solution to this
534 Journal of Manipulative and Physiological TherapeuticsRubinstein et al
October 2014Quality of Trials on Spinal Manipulationproblem is to assess this criterion positively when all expected
(primary) outcomes are reported; however, there is currently
no consensus what those expected outcomes should be.CONCLUSION
This study found that methodological quality of
RCTs of SMT for neck and low back pain is improving over
time, whereas overall sample size has shown only small and
nonsignificant increases. There is an increasing trend among
studies to conduct sample size calculations that relate to
statistical power and probability testing.CONTRIBUTORSHIP INFORMATION
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• This study found that there was significant
improvement in the mean risk of bias over
time (P b .05), which is the most profound for
items related to selection bias and, to a lesser
extent, attrition and selective outcome report-
ing bias.
• Although there was no significant increase in
sample size over time, the proportion of
studies that performed an a priori sample size
calculation is increasing statistically (OR,
2.1; confidence interval, 1.5-3.0).
• We found no difference in effect between
RCTs of SMT, which examined neck and/or
low back pain.REFERENCES
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APPENDIX A. PUBMED SEARCH STRATEGY
On Low Back Pain
((“Low Back Pain”[Mesh] OR “Back Pain”[Mesh])
AND (“Musculoskeletal Manipulations”[Mesh] OR
“Acute Disease”[Mesh] OR “Chronic Disease”[Mesh]
OR “Follow-up Studies”[Mesh]))




(“Neck Pain”[Mesh] AND (“Musculoskeletal Manipula-
tions”[Mesh] OR “Manipulation, Orthopedic”[Mesh] OR
“Acute Disease”[Mesh] OR “Chronic Disease”[Mesh] OR
“Follow-up Studies”[Mesh] OR “Headache/therapy”[Mesh]
OR “Cervical Vertebrae”[Mesh]))
AND (Clinical Trial[ptyp] OR Randomized Controlled
Trial[ptyp])
AND (“2009/07/01”[PDAT]: “3000/12/31”[PDAT]).
These strategies were verified by searching studies that
were included in aforementioned Cochrane reviews. MesH
terms and additional treatments or subtypes were added
after looking into these studies and in order to construct a
reliable, sensitive query. Search strategy was optimized for
searching recent trials (post 2008). Dates mentioned are
always publication dates.
APPENDIX B. OPERATIONALIZATION OF THE RISK OF BIAS CRITERIA
1. Was the method of randomization adequate?
This item was scored low risk if a random (unpredictable)
assignment sequence was used. Examples of adequate
methods are coin toss (for studies with two groups), rolling
a dice (for studies with two or more groups), drawing of balls
of different colors, drawing of ballots with the study group
labels from a dark bag, computer-generated random
sequence, preordered sealed envelopes, sequentially ordered
vials, telephone call to a central office, and preordered list of
treatment assignments. Examples of inadequate methods are
alternation, birth date, social security or insurance number,
date in which subjects are invited to participate in the study,
and hospital registration number.
2. Was the treatment allocation concealed?
This item was scored low risk if the assignment was
generated by an independent person not responsible for
determining the eligibility of the patients. This means that the
person had no information about the persons included in the
trial and had no influence on the assignment sequence or on
the decision about eligibility of the patient.
Was knowledge of the allocated interventions adequately
prevented during the study?
3. Was the patient blinded to the intervention?
This item was scored low risk if the index and control group
(s) was indistinguishable for the patients or if the success
of blinding was tested among the patients and it
was successful.
4. Was the care provider blinded to the intervention?
This itemwas scored low risk if the index and control groups
were indistinguishable for the care providers or if the success
of blinding was tested among the care providers and it was
successful. Comment: This item was always “no” for spinal
manipulative therapy given that it is impossible to blind the
clinician (unlike, for example, medication).
5. Was the outcome assessor blinded to the intervention for
the primary outcomes?
This item was scored low risk if the success of blinding was
tested among the outcome assessors and it was successful.
For patient-reported outcomes, in which the patient is the
outcome assessor (eg, pain, disability, recovery), blinding
was considered adequate if participants were also blinded
to treatment allocation. This is independent of whether the
outcomes were recorded by an independent assessor
blinded to allocation during a clinic visit or outcomes that
were assessed via a questionnaire mailed to the patient.
Studies limited to physiological outcomes were scored as a
“no” as these were not considered relevant outcomes.
Were incomplete outcome data adequately addressed?
6. Was the drop-out rate described and acceptable?
This item was scored low risk if the number of participants
who were included in the study but did not complete the
observation period or were not included in the analysis
were described and reasons given, or in absence of this
information, the percentage of withdrawals and drop-outs
did not exceed 20% for the short-term follow-up (≤3
months) and 30% for long-term follow-up (≥9 months)
and was, therefore, not likely to lead to substantial bias.
7. Were all randomized participants analyzed in the group to
which they were allocated?
This item was scored low risk if all randomized patients were
analyzed in the group to which they were allocated for the
primary outcomes and follow-up measurements, regardless of
noncompliance and cointerventions. This excludes missing
values, meaning imputation (by whatever means) was not
required. This item was also scored as low risk if the number
of subjects dropped from the analysis were not thought to
appreciably affect the outcome(s).
8. Are reports of the study free of suggestion of selective
outcome reporting?
This item was scored low risk if all the results from all
prespecified outcomes were adequately reported. This
determination was made by comparing the protocol
(if available) with the full report/publication; otherwise,
this item was scored “unclear” in the absence of a protocol.
Other sources of potential bias
9. Were the groups similar at baseline regarding the most
important prognostic indicators?
This item was scored low risk if the groups were similar
at baseline regarding the main sociodemographic factors
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(eg, age, gender), duration and severity of complaints, and
value of the main outcome measure(s).
10. Were cointerventions avoided or similar?
This item was scored low risk if there were no cointerventions
or they were similar between the index and control group(s).
11. Was the compliance acceptable in all groups?
This item was scored low risk if the compliance with
the intervention was considered acceptable based upon
the reported intensity, duration, number, and frequency
of sessions for both the index and control group(s).
For example, spinal manipulative therapy is usually
administered over several sessions; therefore, it was
necessary to assess how many sessions had been prescribed
for the patients a priori and whether they attended (most) of
these sessions.
12. Was the timing of the outcome assessment similar in
all groups?
This item was scored low risk if the timing of the outcome
assessment(s) were identical for all groups and for all
important outcome measures.
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